未經受或未患有性交不適或其他外陰陰道萎縮症狀的婦女中在陰道內施用普拉酮睾(DHEA)後性喚起、性需求、性高潮和/或快感的改善
- 专利权人:
- ENDORECHERCHE INC.
- 发明人:
- LABRIE, FERNAND,費爾南德‧萊伯里
- 申请号：
- HK15105870.7
- 公开号：
- HK1204983A
- 申请日:
- 2015.06.19
- 申请国别(地区):
- HK
- 年份:
- 2015
- 代理人:
- 摘要：
- Intravaginal DHEA is used for the treatment of at least one condition selected from the group consisting of female hypoactive sexual desire disorder, female sexual arousal disorder, female orgasm disorder and female sexual interest arousal disorder in a woman who either (1) is not suffering from symptoms of vulvo-vaginal atrophy and/or (2) is not suffering from moderate to severe dyspareunia.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- Prasterone (dehydroepiandrosterone) for intravaginal Treatment of Hypoactive Sexual Desire Disorder Female, Female sexual arousal disorder, disorder of the Female Orgasm and Female sexual arousal disorder interest in women who are not suffering from symptoms of atrophy vulvovagin The dyspareunia and / or moderate to severe； product that understands.
- שיפור גירוי מיני, חשק מיני, אורגזמה ו/או הנאה לאחר מתן פרוגסטרון (dhea) דרך וגינאלי לנשים שאינן סובלות מ–או ללא קשר ל–כאב מגע מיני או תסמינים אחרים של נוון נרתיקי
- IMPROVEMENT OF SEXUAL AROUSAL SEXUAL DESIRE ORGASM AND/OR PLEASURE FOLLOWING INTRAVAGINAL PRASTERONE (DHEA) ADMINISTRATION IN WOMEN NOT SUFFERING OR INDEPENDENTLY FROM DYSPAREUNIA OR OTHER SYMPTOMS OF VULVO VAGINAL ATROPHY
- IMPROVEMENT OF SEXUAL AROUSAL, SEXUAL DESIRE, ORGASM AND/OR PLEASURE FOLLOWING INTRAVAGINAL PRASTERONE (DHEA) ADMINISTRATION IN WOMEN NOT SUFFERING OR INDEPENDENTLY FROM DYSPAREUNIA OR OTHER SYMPTOMS OF VULVO-VAGINAL ATROPHY
- Improvement of sexual arousal, sexual desire, orgasm and/or pleasure following intravaginal prasterone (DHEA) administration in women not suffering or independently from dyspareunia or other symptoms of vulvo-vaginal atrophy
